ANI Pharmaceuticals ANIP Change in Income Taxes
Change in Income Taxes at other companies
Other financials
Where this comes from
Reported directly by ANI Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInIncomeTaxes.
The official record: ANI Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about ANI Pharmaceuticals's change in income taxes.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is ANI Pharmaceuticals's change in income taxes?
- ANI Pharmaceuticals (ANIP) reported change in income taxes of $14.09M in Q1 2026.
- How has ANI Pharmaceuticals's change in income taxes changed year-over-year?
- ANI Pharmaceuticals's change in income taxes increased by 89.4% year-over-year, from $7.44M to $14.09M.
- What is the long-term trend for ANI Pharmaceuticals's change in income taxes?
- Over 3 years (2021 to 2025), ANI Pharmaceuticals's change in income taxes has grown at a 28.3% compound annual growth rate (CAGR), from -$7.57M to -$16M.
- What does change in income taxes mean?
- Change in income tax receivables and payables, reflecting timing between tax accruals and cash payments.